IncFact
Company Profiles: Revenue, Growth, Competition

ARIAD PHARMACEUTICALS Revenue, Growth & Competitor Profile

DBA ARIAD PHAMACEUTICALS, INC
Last updated:

Company Awards

Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Ariad Pharmaceuticals

Access the complete profile.

Ariad Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
44611 Pharmacies & Drug Stores
Address40 Landsdowne St
Cambridge, MA 02139

www.ariad.com


Ariad Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data). It is classified as operating in the Scientific Research & Development Services industry.


Ariad Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Ariad Pharmaceuticals is a publicly traded company on using the ticker symbol ARIA. Detailed information on company financials and operating reports can be found here: : ARIA



Ariad Pharmaceuticals Annual Revenue and Growth Rate

Ariad Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Ariad Pharmaceuticals's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Ariad Pharmaceuticals is developing and marketing. Ariad Pharmaceuticals doesn't have any recent trademark applications, indicating Ariad Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
LIVINGWITHALK
Providing health information, in the field of anaplastic lymphoma kinase positive cancer
10/27/2016
EVOBRIG
Pharmaceutical preparations for use in oncology
09/08/2016
ALKCONNECT
Maintaining a registry of patient data and medical information, in the field of anaplastic lymphoma kinase positive cancer
09/08/2016

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Ariad Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Ariad Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Ariad Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ariad Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM47 
CEPHALONFrazer, PA44 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 
COVANCEPrinceton, NJ27 




Nearby Competitors

These companies are similar in business line and location to Ariad Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ALNYLAM PHARMACEUTICALSCambridge, MA100 
BLUEBIRD BIOCambridge, MA94 
BEIGENE USACambridge, MA64 
ARIAD PHARMACEUTICALSCambridge, MA59 
AGIOS PHARMACEUTICALSCambridge, MA53 
CENTOGENE USCambridge, MA44 




Future Competition: Ariad Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Ariad Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Ariad Pharmaceuticals Competitors